Cardiovascular & Hematological Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Editor-in-Chief:

Debabrata Mukherjee
Department of Internal Medicine
Texas Tech University
El Paso, TX
USA

Back

Become EABM
Become Reviewer

The No-Reflow Phenomenon in the Coronary Circulation

Volume:7   Issue: 3
Pp: 181-192
Thomas J. Kiernan, Nicholas J. Ruggiero II, Juan M. Bernal, Creighton W. Don, Christian Witzke, Gareth D. Kiernan, Roberto J. Cubeddu and Bryan P. Yan
DOI: 10.2174/187152509789105426

Anticoagulation in Patients with Heart Failure

Volume:7   Issue: 3
Pp: 193-197
R. Sacha Bhatia, Maral Ouzounian, Jack V. Tu, Peter P. Liu and Douglas S. Lee
DOI: 10.2174/187152509789105462

Optimal Management of Hypertension in patients with Ischemic Heart Disease

Volume:7   Issue: 3
Pp: 198-205
Debabrata Mukherjee and Charles L. Campbell
DOI: 10.2174/187152509789105435

Phosphodiesterase 3 (PDE3): Structure, Localization and Function

Volume:7   Issue: 3
Pp: 206-211
Taku Murata, Kasumi Shimizu, Kenichi Hiramoto and Toshiro Tagawa
DOI: 10.2174/187152509789105453

Current Pharmacological Approach to Restore Endothelial Dysfunction

Volume:7   Issue: 3
Pp: 212-222
D. Dobarro, M. C. Gomez-Rubin, A. Sanchez-Recalde, R. Moreno, G. Galeote, S. Jimenez-Valero, L. Calvo, E. Lopez de Sa and J. L. Lopez-Sendon
DOI: 10.2174/187152509789105480

Human Plasma Kallikrein-Kinin System: Physiological and Biochemical Parameters

Volume:7   Issue: 3
Pp: 234-250
J. W. Bryant and Z. Shariat-Madar
DOI: 10.2174/187152509789105444

The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease

Volume:7   Issue: 3
Pp: 251-259
P. Mehranpour, S. S. Wang, R. R. Blanco, W. Li, Q. Song, B. Lassegue, S. I. Dikalov, H. Austin and A. M. Zafari
DOI: 10.2174/187152509789105417